source
- European regulators approve Fractyl Health's first GLP-1 gene therapy clinical trialEuropean regulators have given the green light for Fractyl Health, a biotech near Boston, to begin its first human study of a GLP-1 gene therapy. The therapy aims to provide a one-time treatment t…
- Specialized logistics critical for delivering next-generation cell and gene therapiesThe article explains that personalized medicines such as cell and gene therapies are transforming treatment for rare diseases and cancers. Unlike conventional drugs, these therapies are often made…